NEWS

VANCOUVER, B.C. – Chesapeake Gold Corp. (TSXV:CKG, OTCQX:CHPGF) (“Chesapeake” or the “Company”) announces that further to its news release dated November 13, 2024, it has filed an appeal with the Collegiate Court in Mexico of the decision of the North Center III and Auxiliary Regional Chamber of the Federal Court of Administrative Justice upholding the cancellation of the San Vicente 3 mineral concession (“San Vicente 3”) by the Dirección General de Minas of Mexico (“DGM”). The Company has appealed the decision to the Collegiate Court on the basis that the Chamber had erroneously found that the DGM had complied with mandated cancellation procedures and, therefore, it violated the Company’s fundamental

VANCOUVER, B.C. – Chesapeake Gold Corp. (TSXV:CKG, OTCQX:CHPGF) (“Chesapeake” or the “Company”) announces the grant of stock options under its Stock Option Plan to purchase an aggregate of 65,000 common shares of the Company at an exercise price of C$1.80 per share for a five-year term expiring November 5, 2029. The stock options were granted to officers of the Company. The options will vest and be exercisable on the basis of 25% annually, commencing November 5, 2025, the first anniversary of the date of the grant. About Chesapeake Chesapeake Gold Corp’s flagship asset is the Metates Project (“Metates”) located in Durango State, Mexico. Metates hosts one of the largest undeveloped gold-silver deposits in

VANCOUVER, B.C. – Chesapeake Gold Corp. (TSXV:CKG, OTCQX:CHPGF) (“Chesapeake” or the “Company”) is pleased to provide a metallurgical update for its Metates gold-silver project located in Durango State, Mexico and an update regarding the latest developments on the Company’s intellectual property rights. Jean-Paul Tsotsos, Interim Chief Executive Officer, commented, “We are pleased that the metallurgical test work achieved gold recovery rates exceeding 70%, providing verification that our proprietary oxidative leach technology (the “Technology”) is working as planned. These test results will be the foundation for a Metates pre-feasibility study (“PFS”). Looking further ahead, the recent acquisition of certain intellectual property rights (See press release dated June 5, 2024) was a